USPTO serial 97784457
KITE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 9, 2024
- Examiner
- FLINT, DANIEL LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with KITE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Santa Monica, CA, US
Santa Monica, CA, US
Santa Monica, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Smuzynska
Cynthia Smuzynska GILEAD SCIENCES, INC.333 LAKESIDE DRIVEFOSTER CITY, CA 94404UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 036 | Financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services | ACTIVE | Jan 1, 2020 |
| 040 | Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy | ACTIVE | Jun 30, 2020 |
| 044 | Providing medical information in the fields of oncology, immunology and cell therapy; providing a web site featuring medical information in the fields of oncology, immunology and cell therapy; providing medical information, consultancy and advisory services in the fields of oncology, immunology and cell therapy; all of the foregoing excluding any services related to optometry, ophthalmology or other ocular care; collection and preservation of biological tissue, blood and cells | ACTIVE | Jun 25, 2021 |
| 045 | Providing patient advocate services in the field of the treatment of diseases and disorders in the fields of cancer treatments, immunotherapy and cell therapy treatments | ACTIVE | Jan 1, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Kite Pharma, Inc.
- Other trademarks owned by Kite Pharma, Inc.
- Other trademarks owned by Kite Pharma, Inc.
- Other trademarks in Class 036
- Other trademarks in Class 040
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named KITE
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 16, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 12, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 12, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 12, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 12, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 13, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Sep 13, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 15, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 10, 2023 | NWAP | NEW APPLICATION ENTERED | — |